0
13
Journal Articles about Antipsychotics Showing 201-220 of 931
Article | May 01, 2000
Normal P50 Suppression in Schizophrenia Patients Treated With Atypical Antipsychotic Medications
Gregory A. Light, B.A.; Mark A. Geyer, Ph.D.; Brett A. Clementz, Ph.D.; Kristin S. Cadenhead, M.D.; David L. Braff, M.D.
The American Journal of Psychiatry. 2000 May ; 5(157):767-771
PDFPDF
Regular Article | April 01, 2000
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
Shitij Kapur, M.D., Ph.D., F.R.C.P.C.; Robert Zipursky, M.D., F.R.C.P.C.; Corey Jones, B.A.; Gary Remington, M.D., Ph.D., F.R.C.P.C.; Sylvain Houle, M.D., Ph.D., F.R.C.P.C.
The American Journal of Psychiatry. 2000 April ; 4(157):514-520
PDFPDF
Brief Report | February 01, 2000
Striatal Dopamine Transporter Binding in Neuroleptic-Naive Patients With Schizophrenia Studied With Positron Emission Tomography
Aki Laakso, M.D., Ph.D.; Harry Vilkman, M.D.; Birgitta Alakare, M.D.; Merja Haaparanta, M.Sc.; Jörgen Bergman, M.Sc.; Olof Solin, Ph.D.; Jari Peurasaari, M.D.; Viljo Räkköläinen, M.D., Ph.D.; Erkka Syvälahti, M.D., Ph.D.; Jarmo Hietala, M.D., Ph.D.
The American Journal of Psychiatry. 2000 February ; 2(157):269-271
PDFPDF
Special Article | November 01, 1999
Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis
David B. Allison, Ph.D.; Janet L. Mentore, M.S.Ed.; Moonseong Heo, Ph.D.; Linda P. Chandler, Ph.D.; Joseph C. Cappelleri, Ph.D., M.P.H.; Ming C. Infante, M.S.; Peter J. Weiden, M.D.
The American Journal of Psychiatry. 1999 November ; 11(156):1686-1696
PDFPDF
Regular Article | September 01, 1999
Risperidone in Treatment-Refractory Schizophrenia
Donna A. Wirshing, M.D.; Barringer D. Marshall, Jr., M.D.; Michael F. Green, Ph.D.; Jim Mintz, Ph.D.; Stephen R. Marder, M.D.; William C. Wirshing, M.D.
The American Journal of Psychiatry. 1999 September ; 9(156):1374-1379
PDFPDF
Brief Report | August 01, 1999
Clozapine-Associated Elevation in Serum Triglycerides
Bruce D. Gaulin, M.S., Pharm.; John S. Markowitz, Pharm.D.; Charles F. Caley, Pharm.D.; Lori A. Nesbitt, Pharm.D.; Robert L. Dufresne, Ph.D.
The American Journal of Psychiatry. 1999 August ; 8(156):1270-1272
PDFPDF
Brief Report | August 01, 1999
Tetrabenazine Treatment for Tardive Dyskinesia: Assessment by Randomized Videotape Protocol
William G. Ondo, M.D.; Philip A. Hanna, M.D.; Joseph Jankovic, M.D.
The American Journal of Psychiatry. 1999 August ; 8(156):1279-1281
PDFPDF
Regular Article | August 01, 1999
Change in Basal Ganglia Volume Over 2 Years in Patients With Schizophrenia: Typical Versus Atypical Neuroleptics
Patricia Westmoreland Corson, M.D.; Peg Nopoulos, M.D.; Del D. Miller, Pharm.D., M.D.; Stephan Arndt, Ph.D.; Nancy C. Andreasen, M.D., Ph.D.
The American Journal of Psychiatry. 1999 August ; 8(156):1200-1204
PDFPDF
Regular Article | July 01, 1999
Normalization of Information Processing Deficits in Schizophrenia With Clozapine
Veena Kumari, Ph.D.; William Soni, M.B., B.S., M.Sc.; Tonmoy Sharma, M.Sc., M.R.C.Psych.
The American Journal of Psychiatry. 1999 July ; 7(156):1046-1051
PDFPDF
Special Article | July 01, 1999
Evidence of Clozapine’s Effectiveness in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Trials
Kristian Wahlbeck, M.D., Ph.D.; Maxim Cheine, M.D.; Adib Essali, M.D., Ph.D., M.R.C.Psych.; Clive Adams, M.B., B.Ch., B.A.O., M.R.C.Psych., M.Sc.(Epid.)
The American Journal of Psychiatry. 1999 July ; 7(156):990-999
PDFPDF
Regular Article | June 01, 1999
Rehospitalization Rates of Patients Recently Discharged on a Regimen of Risperidone or Clozapine
Robert R. Conley, M.D.; Raymond C. Love, Pharm.D.; Deanna L. Kelly, Pharm.D., BCCP; John J. Bartko, Ph.D.
The American Journal of Psychiatry. 1999 June ; 6(156):863-868
PDFPDF
Regular Article | June 01, 1999
Suggested Minimal Effective Dose of Risperidone Based on PET-Measured D2 and 5-HT2A Receptor Occupancy in Schizophrenic Patients
Svante Nyberg, M.D., Ph.D.; Bo Eriksson, B.Sc.; Gabriella Oxenstierna, M.D.; Christer Halldin, Ph.D.; Lars Farde, M.D., Ph.D.
The American Journal of Psychiatry. 1999 June ; 6(156):869-875
PDFPDF
Regular Article | June 01, 1999
Rapid Release of Antipsychotic Drugs From Dopamine D2 Receptors: An Explanation for Low Receptor Occupancy and Early Clinical Relapse Upon Withdrawal of Clozapine or Quetiapine
Philip Seeman, M.D., Ph.D.; Teresa Tallerico, Ph.D.
The American Journal of Psychiatry. 1999 June ; 6(156):876-884
PDFPDF
Regular Article | June 01, 1999
Persistence of Haloperidol in Human Brain Tissue
Johannes Kornhuber, M.D.; Andreas Schultz; Jens Wiltfang, M.D.; Ingolf Meineke, Ph.D.; Christoph H. Gleiter, M.D.; Robert Zöchling, M.D.; Karl-Werner Boissl, M.D.; Friedrich Leblhuber, M.D.; Peter Riederer, Ph.D.
The American Journal of Psychiatry. 1999 June ; 6(156):885-890
PDFPDF
Regular Article | May 01, 1999
Olanzapine Versus Placebo in the Treatment of Acute Mania
Mauricio Tohen, M.D., Dr.P.H.; Todd M. Sanger, Ph.D.; Susan L. McElroy, M.D.; Gary D. Tollefson, M.D., Ph.D.; K.N. Roy Chengappa, M.D.; David G. Daniel, M.D.; Frederick Petty, M.D., Ph.D.; Franca Centorrino, M.D.; Richard Wang, M.D., Ph.D.; Starr L. Grundy, B.Sc.Pharm.; Michael G. Greaney, M.S.; Thomas G. Jacobs, M.A.S.; Stacy R. David, Ph.D.; Verna Toma, B.S.; The Olanzapine HGEH Study Group
The American Journal of Psychiatry. 1999 May ; 5(156):702-709
PDFPDF
Brief Report | April 01, 1999
Sexual Disturbances During Clozapine and Haloperidol Treatment for Schizophrenia
Martina Hummer, M.D.; Georg Kemmler, Ph.D.; Martin Kurz, M.D.; Ilsemarie Kurzthaler, M.D.; Harald Oberbauer, M.D.; W. Wolfgang Fleischhacker, M.D.
The American Journal of Psychiatry. 1999 April ; 4(156):631-633
PDFPDF
Brief Report | April 01, 1999
Increase in Expression of Adhesion Molecule Receptors on T Helper Cells During Antipsychotic Treatment and Relationship to Blood-Brain Barrier Permeability in Schizophrenia
Norbert M�ller, M.D., Ph.D.; Michael Riedel, M.D.; Myriam Hadjamu, M.D.; Markus J. Schwarz, M.D.; Manfred Ackenheil, M.D.; Rudolf Gruber, M.D.
The American Journal of Psychiatry. 1999 April ; 4(156):634-636
PDFPDF
Regular Article | April 01, 1999
Improvement of Schizophrenic Patients With Primary Negative Symptoms Treated With Amisulpride
Jean-Marie Danion, M.D.; Werner Rein, M.D.; Odile Fleurot, M.D.; the Amisulpride Study Group
The American Journal of Psychiatry. 1999 April ; 4(156):610-616
PDFPDF
Regular Article | March 01, 1999
Comparative Effectiveness of Fluphenazine Decanoate Injections Every 2 Weeks Versus Every 6 Weeks
William T. Carpenter, Jr., M.D.; Robert W. Buchanan, M.D.; Brian Kirkpatrick, M.D.; Helen D. Lann, M.D.; Alan F. Breier, M.D.; Ann T. Summerfelt
The American Journal of Psychiatry. 1999 March ; 3(156):412-418
PDFPDF
Brief Report | February 01, 1999
Incidence of Tardive Dyskinesia in Early Stages of Low-Dose Treatment With Typical Neuroleptics in Older Patients
Dilip V. Jeste, M.D.; Jonathan P. Lacro, Pharm.D.; Barton Palmer, Ph.D.; Enid Rockwell, M.D.; M. Jackuelyn Harris, M.D.; Michael P. Caligiuri, Ph.D.
The American Journal of Psychiatry. 1999 February ; 2(156):309-311
PDFPDF
Copyright ©
American
Psychiatric
Association